MetroPCS Communications Inc (NYSE:PCS) disclosed on Wednesday that an 8% drop in profit for the Q1 as a slight surge in revenues were offset by merger-related costs and a higher tax provision. Adjusted EPS missed analysts’ prospects, whereas revenues matched their predicts.
As the average revenue per user or ARPU in the quarter was $40.96, a surge of $0.40 over the previous-year quarter. The boost reflects continued demand for the firm’s 4G LTE service plans, partly offset by promotional service plans.
The average monthly churn rate plunged 20 basis points from the year-before quarter to 2.9%, the lowest quarterly churn in firm history. The plunge in churn was primarily driven by continued investments in the firm’s network and lower subscriber growth.
Moving readers toward the broader market, let’s consider percentage change in stocks prices of other stocks in the similar sector who contribute major role in the market that includes Sprint Nextel Corporation (NYSE:S) lost -0.14%, Vodafone Group Plc (ADR) (NASDAQ:VOD) edged down -0.69%, America Movil SAB de CV (ADR) (NYSE:AMX) which also increased +1.00% and Clearwire Corporation (NASDAQ:CLWR) closed up +1.22%.
MetroPCS Communications Inc (NYSE:PCS) stock’s trade at beginning with a price of $11.70 and throughout the trading session climbed at a high of $11.79 other than when day-trade ended the stock finally advanced +0.68% to $11.77.
The stock is going forward its 52 week low with +112.84% and lagging behind from its 52 week high price with -18.88%. PCS last month stock price volatility remained 2.87%.
PCS stock institutional ownership remained 92.80% while insider ownership included 1.52%. In its share capital PCS has 367.89 million outstanding shares among them 361.35 million shares have been floated in market exchange.
Company’s beta coefficient included 0.83. Beta factors measures the amount of market risk associated with market trade.
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Entire Disclaimer Here